Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.
about
Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.Metformin and lung cancer risk in patients with type 2 diabetes mellitus.New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers.New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity.
P2860
Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rh2E2, a novel metabolic suppr ...... sed metabolism of tumor cells.
@en
type
label
Rh2E2, a novel metabolic suppr ...... sed metabolism of tumor cells.
@en
prefLabel
Rh2E2, a novel metabolic suppr ...... sed metabolism of tumor cells.
@en
P2093
P2860
P356
P1433
P1476
Rh2E2, a novel metabolic suppr ...... ased metabolism of tumor cells
@en
P2093
Ah Ng Tony Kong
Betty Yuen Kwan Law
Elaine Lai Han Leung
Feng Gen Yen
Jianru Guo
Jingrong Wang
Ka Man Chan
Li-Ping Bai
P2860
P304
P356
10.18632/ONCOTARGET.6934
P407
P577
2016-03-01T00:00:00Z